{"version":"1.0","provider_name":"Archila Abogados","provider_url":"https:\/\/archilaabogados.com\/en","title":"Control del monopolio de medicamentos - Archila Abogados","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3ld2r1dnmn\"><a href=\"https:\/\/archilaabogados.com\/en\/2017\/12\/14\/control-del-monopolio-de-medicamentos\/\">Control del monopolio de medicamentos<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/archilaabogados.com\/en\/2017\/12\/14\/control-del-monopolio-de-medicamentos\/embed\/#?secret=3ld2r1dnmn\" width=\"600\" height=\"338\" title=\"&#8220;Control del monopolio de medicamentos&#8221; &#8212; Archila Abogados\" data-secret=\"3ld2r1dnmn\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/archilaabogados.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"http:\/\/archilaabogados.com\/wp-content\/uploads\/2017\/12\/medicamentos.jpg","thumbnail_width":240,"thumbnail_height":290,"description":"Bogot\u00e1. 18\/11\/2017. Art\u00edculo escrito por el Dr. Emilio Jos\u00e9 Archila \u00bfSe justifica la limitaci\u00f3n de los derechos econ\u00f3micos de las farmac\u00e9uticas a trav\u00e9s del control de precios? Con la inclusi\u00f3n de 222 nuevos medicamentos en la lista de control de precios directo que hizo hace unos d\u00edas el Ministerio de Salud, se pone nuevamente sobre..."}